We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

40 hedge funds and large institutions have $7.93M invested in Annovis Bio in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

63% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 8

14% more funds holding

Funds holding: 35 → 40 (+5)

2.38% more ownership

Funds ownership: 9.03% → 11.42% (+2.4%)

17% less capital invested

Capital invested by funds: $9.5M → $7.93M (-$1.58M)

41% less call options, than puts

Call options by funds: $1.99M | Put options by funds: $3.38M

Holders
40
Holders Change
+5
Holders Change %
+14.29%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
8
Closed
4
Calls
$1.99M
Puts
$3.38M
Net Calls
-$1.39M
Net Calls Change
+$7.26M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$814K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$623K
3
MFG
Merit Financial Group
Georgia
+$520K
4
CSS
Cubist Systematic Strategies
Connecticut
+$372K
5
Jane Street
Jane Street
New York
+$347K

Top Sellers

Rank Fund Capital Flow
1
A
AlphaQuest
New York
-$371K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$197K
3
Group One Trading
Group One Trading
Illinois
-$192K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$109K
5
SIAP
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
-$76K
Name Holding Trade Value Shares
Change 		Change in
Stake
WSFS
26
Wilmington Savings Fund Society
Delaware
$47.2K – – –
JP Morgan Chase
27
JP Morgan Chase
New York
$19.1K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$8.89K -$9.55K -1,319 -43%
RS
29
R Squared
Hong Kong
$7.65K +$11K +1,520 New
Morgan Stanley
30
Morgan Stanley
New York
$6.54K -$362 -50 -4%
DPW
31
DiNuzzo Private Wealth
Pennsylvania
$5.03K +$7.24K +1,000 New
BF
32
BOK Financial
Oklahoma
$2.71K – – –
Osaic Holdings
33
Osaic Holdings
Arizona
$2.52K -$5.05K -698 -58%
SS
34
SBI Securities
Japan
$2.03K +$2.92K +403 New
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$1.76K – – –
GPFA
36
Game Plan Financial Advisors
Ohio
$1K – – –
WWP
37
WR Wealth Planners
Missouri
$755 – – –
Bank of America
38
Bank of America
North Carolina
$423 -$43.4K -5,996 -99%
EWA
39
EverSource Wealth Advisors
Alabama
$417 – – –
CIAM
40
Caitong International Asset Management
Hong Kong
$397 +$572 +79 New
A
41
AlphaQuest
New York
– -$371K -46,002 Closed
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
– -$197K -24,410 Closed
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
– -$109K -13,500 Closed
Simplex Trading
44
Simplex Trading
Illinois
– -$62.3K -8,605 Closed
1
2

ANVS Hedge Fund Activity: Q4 2024 in Review

40 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q4 2024, worth a combined $7.93M — down 17% from $9.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ANVS positions and 4 closed out — a net gain of 5 holders — while 13 added to existing stakes and 8 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $814K. The largest seller was AlphaQuest, exiting entirely with an estimated $371K sold.

  • 40 institutional investors held Annovis Bio (ANVS) as of Q4 2024, up from 35 in Q3 2024.
  • Funds reported $7.93M of Annovis Bio stock for Q4 2024, down 17% quarter-over-quarter.
  • 9 funds opened new Annovis Bio positions in Q4 2024 and 4 closed out, a net change of +5 holders.
  • The largest Annovis Bio buyer in Q4 2024 was Citadel Advisors, an estimated $814K added.
  • The largest Annovis Bio seller in Q4 2024 was AlphaQuest, an estimated $371K sold.

Based on aggregated 13F filings for Q4 2024.